Task: Answer Verification
Input (English): Question: Does maraviroc concentrate in the cervicovaginal fluid and vaginal tissue of HIV-negative women?
Answer: Higher maraviroc exposure in the female genital tract provides a pharmacologic basis for further evaluation of chemokine receptor 5 antagonists in HIV infection prophylaxis. This is the first study to report antiretroviral VT concentrations, CVF protein binding, and CVF terminal elimination.
Output (English): yes